AWA
GILD icon

Arete Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Arete Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,568
Closed -$1.3M – 474
2025
Q4 		$1.3M Sell
10,568
-656
-6% -$79.7K 0.08% 241
2025
Q3 		$1.25M Sell
11,224
-755
-6% -$85.8K 0.08% 240
2025
Q2 		$1.33M Buy
11,979
+684
+6% +$72.8K 0.09% 213
2025
Q1 		$1.26M Buy
11,295
+386
+4% +$39.8K 0.1% 217
2024
Q4 		$1M Buy
10,909
+1,125
+11% +$101K 0.07% 254
2024
Q3 		$817K Sell
9,784
-802
-8% -$61.2K 0.07% 262
2024
Q2 		$723K Sell
10,586
-453
-4% -$30.2K 0.06% 304
2024
Q1 		$809K Sell
11,039
-3,224
-23% -$248K 0.07% 238
2023
Q4 		$1.16M Buy
14,263
+988
+7% +$76.9K 0.09% 223
2023
Q3 		$995K Sell
13,275
-2,351
-15% -$181K 0.17% 128
2023
Q2 		$824K Buy
15,626
+5,504
+54% +$439K 0.07% 246
2023
Q1 		$840K Sell
10,122
-5,270
-34% -$436K 0.07% 244
2022
Q4 		$1.32B Buy
15,392
+3,761
+32% +$298K 0.12% 157
2022
Q3 		$717K Buy
11,631
+6,860
+144% +$433K 0.07% 232
2022
Q2 		$295K Buy
4,771
+867
+22% +$53.7K 0.03% 336
2022
Q1 		$232K Buy
3,904
+604
+18% +$38.6K 0.02% 444
2021
Q4 		$239K Buy
3,300
+22
+0.7% +$1.51K 0.02% 430
2021
Q3 		$229K Buy
+3,278
New +$230K 0.03% 377
2020
Q3 		– Sell
-3,141
Closed -$242K – 394
2020
Q2 		$242K Buy
+3,141
New +$241K 0.04% 325
2018
Q2 		– Sell
-12,836
Closed -$968K – 373
2018
Q1 		$968K Sell
12,836
-852
-6% -$67.7K 0.32% 80
2017
Q4 		$981K Sell
13,688
-961
-7% -$73K 0.32% 76
2017
Q3 		$1.19M Buy
14,649
+5,233
+56% +$400K 0.47% 59
2017
Q2 		$666K Buy
9,416
+1,093
+13% +$72.7K 0.3% 92
2017
Q1 		$565K Sell
8,323
-215
-3% -$15.1K 0.25% 90
2016
Q4 		$611K Buy
+8,538
New +$635K 0.28% 77

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Arete Wealth Advisors's GILD Position: Q1 2026 in Review

Arete Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 10,568 shares — an estimated $1.3M sold.

Arete Wealth Advisors first reported a position in GILD in Q4 2016 and held it in 25 quarters. The position peaked at $1.32B in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Arete Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 10,568 Gilead Sciences shares in Q1 2026, an estimated $1.3M.
  • Arete Wealth Advisors first reported a position in Gilead Sciences in Q4 2016 and held it in 25 quarters.
  • Arete Wealth Advisors's Gilead Sciences position peaked at $1.32B in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.